Knowledge Center
Article / Aug 30, 2016
Accelerating approval and reducing costs of spray dried drugs through development by design
Source:
Pharma's Almanac, Global Pharmaceutical Supply Chain Trends, Q3 2016
Contract development and manufacturing organizations with unique technical capabilities and expertise are able to speed up the development and commercialization of novel medicines. Effective application of its extensive knowledge, data base and Development by Design approach has enabled Hovione to accelerate spray drying development, simultaneously reducing cost and time to get challenging drugs to patients in need.
Related links
Also in the Knowledge Center
Scientific Article
Scientific Article
/ Jan 04, 2021
QbD approach to downstream processing of spray-dried amorphous solid dispersions – a case study
Read more
Scientific Article